spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Kensey Nash 

 HSMN NewsFeed - 3 Jan 2018
Recro Pharma Announces Key Executive Promotions to the Financial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2016
Recro Pharma Appoints Michael Celano as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2015
Makindus Bolsters Management Team with Appointment of Michael Celano as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 3 May 2012
Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
Devices Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2011
Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes
Devices Interventional
 HSMN NewsFeed - 23 Sep 2011
Kensey Nash Corporation Announces the Addition of Lisa Earnhardt to its Board of Directors
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 16 Feb 2011
Orthovita Launches Vitoss(TM) Bioactive Foam-2X Bone Graft Substitute at AAOS (American Academy of Orthopedic Surgeons) Meeting
Devices Orthopaedic
 HSMN NewsFeed - 10 Feb 2011
Orthovita Receives FDA Clearance for Vitoss(TM) Bimodal Bone Graft Substitute
Devices Orthopaedic Regenerative Medicine FDA
 HSMN NewsFeed - 31 Jan 2011
Kensey Nash Acquires Medical Adhesives and Coatings Technology
Devices Surgery Regenerative Medicine Acquisitions
 HSMN NewsFeed - 7 Dec 2010
Orthovita Receives FDA Clearance for Vitoss(TM) Bioactive Foam-2X Bone Graft Substitute
Devices Orthopaedic FDA
 HSMN NewsFeed - 9 Nov 2010
Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device
Regenerative Medicine Orthopaedic Distribution
 HSMN NewsFeed - 24 Jun 2010
Kensey Nash and Arthrex Announce Strategic Agreement for Extracellular Matrix Products
Devices Orthopaedic Regenerative Medicine
 HSMN NewsFeed - 23 Jun 2010
Kensey Nash Announces New Collagen Supply Agreement With St. Jude Medical
Devices Interventional
 HSMN NewsFeed - 26 May 2010
KENSEY NASH Receives FDA 510(k) Clearance for ECM Product, Meso BioMatrix Surgical Mesh
Devices Surgery FDA
 HSMN NewsFeed - 17 Mar 2010
Caron D'Ambruso Joins SafeStitch as Vice President of Sales and Marketing
Devices Surgery Personnel
 HSMN NewsFeed - 20 Aug 2009
Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
Devices Regenerative Medicine
 HSMN NewsFeed - 7 Aug 2009
Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
Devices Distribution
 HSMN NewsFeed - 23 Jun 2009
ThromCat(R) XT(TM) Thrombectomy Catheter System Receives CE Mark
Devices Interventional Regulatory
 HSMN NewsFeed - 23 Jun 2009
Spectranetics Receives CE Mark Approval for ThromCat(R)XT
Devices Interventional Regulatory
 HSMN NewsFeed - 4 Feb 2009
Kensey Nash Announces Director Resignation
Devices Interventional Personnel
 HSMN NewsFeed - 16 Dec 2008
Globus Medical Strengthens Executive Team with Appointment of CFO
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 23 Oct 2008
Kensey Nash Corporation Announces Resignation of Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 22 Sep 2008
Orthovita Announces New VITOSS Bioactive Foam Pack Bone Graft Substitute
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 27 Aug 2008
Spectranetics Announces First Laser Lead Extraction Procedures in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Aug 2008
Spectranetics Takes Steps Targeted at Accelerating Vascular Intervention Growth
Devices Interventional Personnel
 HSMN NewsFeed - 7 Jul 2008
Spectranetics Appoints Michael Voss as Vice President and General Manager of Vascular Intervention Business
Devices Interventional Personnel
 HSMN NewsFeed - 2 Jun 2008
Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics
Devices Interventional Acquisitions
 HSMN NewsFeed - 2 Jun 2008
Spectranetics Announces Closing of Transaction to Acquire Endovascular Business of Kensey Nash
Devices Interventional Acquisitions
 HSMN NewsFeed - 13 May 2008
Spectranetics Acquires Endovascular Business of Kensey Nash
Devices Interventional Acquisitions
 HSMN NewsFeed - 13 May 2008
Kensey Nash Announces Sale of Endovascular Business and Strategic Partnership With Spectranetics
Devices Interventional Acquisitions
 HSMN NewsFeed - 14 Apr 2008
Orthovita Introduces VITASURE(TM) Absorbable Hemostat as Part of its Strategy to Leverage its Biomaterials Sales Organization
Devices Distribution
 HSMN NewsFeed - 20 Feb 2008
Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
Devices Interventional FDA
 HSMN NewsFeed - 15 Jan 2008
Orthovita Submits 510(k) Application to FDA for the Use of CORTOSS(R) Bone Augmentation Material in Vertebral Augmentation
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 15 Nov 2007
Kensey Nash Meets Milestone Event for OsseoFit(TM) Porous Tissue Matrix(TM) Proprietary Bone Void Filler
Devices Orthopaedic
 HSMN NewsFeed - 2 Nov 2007
Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
Devices Licensing Interventional
 HSMN NewsFeed - 25 Oct 2007
Kensey Nash Reaches Agreement with Ramius on New Board Nominees
Devices Interventional Orthopaedic Personnel
 HSMN NewsFeed - 6 Aug 2007
Orthovita Receives CE Mark for VITAGEL(R) Surgical Hemostat and CELLPAKER(R) Plasma Collection System
Devices Regulatory
 HSMN NewsFeed - 10 Jul 2007
Kensey Nash to Exit Embolic Protection Markets
Devices Interventional
 HSMN NewsFeed - 18 Jun 2007
Kensey Nash Announces Results of EU Coronary Study Using the Thromcat(TM) Thrombectomy Catheter System
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Jun 2007
Cytori Divests HYDROSORB(TM) Surgical Implant Product Line to Kensey Nash for $3.2 Million
Devices Orthopaedic Neurosurgery Acquisitions
 HSMN NewsFeed - 1 Jun 2007
Kensey Nash Announces Acquisition of Assets of MacroPore Biosurgery Business Unit from Cytori Therapeutics
Devices Orthopaedic Neurosurgery Acquisitions
 HSMN NewsFeed - 10 Apr 2007
Kensey Nash Receives Expanded CE Mark Approval for TriActiv(R) ProGuard(TM) Embolic Protection System in Carotid Anatomy
Devices Interventional Regulatory
 HSMN NewsFeed - 21 Mar 2007
Biomet and Kensey Nash Announce Exclusive Marketing and Distribution Agreement for OrthoFill(TM) Proprietary Bone Void Filler
Devices Orthopaedic Distribution
 HSMN NewsFeed - 21 Feb 2007
Orthovita Announces Completion of Patient Enrollment in Its U.S. Pivotal Clinical Study for the Use of CORTOSS(R) in the Treatment of Vertebral Compression Fractures
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 7 Feb 2007
Orthovita Announces Appointment of Chief Business Officer and Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 5 Feb 2007
Orthovita Confirms That 510(k) Submission May Be Used to Seek Clearance for CORTOSS(R) Bone Augmentation Material for the Treatment of Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 22 Jan 2007
FDA Approves Orthovita's PMA Supplement for the CELLPAKER(R) Plasma Collection System Used in Conjunction with the VITAGEL(R) Surgical Hemostat
Devices FDA
 HSMN NewsFeed - 14 Nov 2006
Kensey Nash Announces Commencement of Carotid Pivotal Trial for TriActiv ProGuard System
Devices Interventional
 HSMN NewsFeed - 8 Nov 2006
Orthovita Enters into Binding Letter of Intent to Purchase the VITAGEL(TM) Profit-Sharing Royalty Rights From Angiotech Pharmaceuticals (US), Inc.
Devices Licensing
 HSMN NewsFeed - 23 Oct 2006
Kensey Nash Receives CE Mark Approval for New ThromCat(TM) Thrombectomy Catheter System
Devices Interventional
 HSMN NewsFeed - 9 Oct 2006
First U.S. Presentation of CORTOSS(R) IDE Pivotal Clinical Preliminary Data to Be Presented in a Poster at the Congress of Neurological Surgeons in Chicago
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 27 Sep 2006
Kensey Nash Announces 510(K) Clearance for Proprietary Bone Void Filler
Devices Orthopaedic FDA
 HSMN NewsFeed - 14 Sep 2006
Orthovita Announces First Public Podium Presentation of CORTOSS(R) IDE Pivotal Clinical Data in the Treatment of Vertebral Compression Fractures at the European Society of Neuroradiology Meeting in Geneva
Devices Orthopaedic
 HSMN NewsFeed - 12 Sep 2006
Albert J. Pavucek, Jr. Joins Orthovita as Vice President Corporate Controller
Devices Personnel
 HSMN NewsFeed - 24 Jul 2006
Kensey Nash Receives CE Mark Approval for QuickCat(TM) Extraction Catheter
Devices Regulatory Interventional
 HSMN NewsFeed - 12 Jul 2006
Kensey Nash Receives FDA 510(k) Clearance for TriActiv FX(R) Embolic Protection System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 16 Jun 2006
Orthovita Receives FDA Approval to Market Its VITAGEL(TM) Surgical Hemostat
Devices Surgery FDA
 HSMN NewsFeed - 26 May 2006
Kensey Nash Announces Acquisition of Assets of IntraLuminal Therapeutics, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 1 May 2006
Two CORTOSS(R) Scientific Papers Will Be Presented at the 44th Annual Meeting of the American Society for Neuroradiology
Devices
 HSMN NewsFeed - 27 Apr 2006
Kensey Nash Receives FDA 510(k) Clearance for New ThromCat(TM) Thrombectomy Catheter System
Devices FDA
 HSMN NewsFeed - 26 Apr 2006
Kensey Nash Announces Completion of Carotid Pilot Trial Using the TriActiv(R) ProGuard(TM) System
Devices Interventional
 HSMN NewsFeed - 25 Apr 2006
Orthovita Expands Management Team with Addition of Christine J. Arasin as Vice President Business Development and Corporate Counsel
Devices Personnel
 HSMN NewsFeed - 17 Apr 2006
FDA Approves Further Changes To CORTOSS(R) IDE Pivotal Study Protocol
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 20 Mar 2006
Orthovita and Aastrom Biosciences Announce Collaboration Agreement for Orthopedic Products
Biopharmaceuticals Regenerative Medicine Orthopaedic
 HSMN NewsFeed - 10 Mar 2006
Kensey Nash Receives FDA 510(k) Clearance for QuickCat(TM) Extraction Catheter
Devices Interventional FDA
 HSMN NewsFeed - 7 Mar 2006
Kensey Nash Announces Low 3.2% MACE Rate Achieved Using New TriActiv FX(R) Embolic Protection System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Feb 2006
Kensey Nash Receives CE Mark Approval for New TriActiv(R) ProGuard(TM) Embolic Protection System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 2 Feb 2006
Rheologics Appoints Dr. Ralph E. Holsworth, Jr. to Management Team
Devices Personnel
 HSMN NewsFeed - 23 Jan 2006
Kensey Nash Submits TriActiv FX(R) Embolic Protection System 510(k) Application to FDA
Devices Interventional FDA
 HSMN NewsFeed - 12 Jan 2006
Kensey Nash Submits QuickCat(TM) Extraction Catheter 510(k) Application to FDA
Devices FDA
 HSMN NewsFeed - 5 Jan 2006
Kensey Nash Submits ThromCat(TM) Thrombectomy System 510(k) Application to FDA
Devices Interventional FDA
Return to NewsFeed  

 Additional items found! 52

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 52 additional stories matching:
Kensey Nash
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.